Emmarlinkpharma Private Limited, a active private limited company, was established on 19 March 2019 in Kannur, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999KL2019PTC057236. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹7.30 Cr and a paid-up capital of ₹6.41 Cr.
It upholds a compliant status. Employing 10 professional, Its leadership includes Ramakrishnan Makuni Varayil (Director), Makkuni Amritha Ramakrishnan (Director), Praveen Damodar (Director). Past directors included Ramakrishnan Makuni Varayil. It holds ₹18.02 Cr open charges and ₹17.25 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Building No. 52/5287 Haji Building, Fort Road, Kannur, Kerala, 670001.
U74999KL2019PTC057236
057236
19 March 2019
₹7.30 Cr
₹6.41 Cr
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Emmarlinkpharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishnan Makuni Varayil | Director | 24 Jan 2022 | Current |
| Makkuni Amritha Ramakrishnan | Director | 19 Mar 2019 | Current |
| Praveen Damodar | Director | 19 Mar 2019 | Current |
| Aishwarya Praveen | Director | 19 Mar 2019 | Current |
| Girija Ramakrishnan | Director | 19 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Emmarlinkpharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.45% increase. The company also saw a slight improvement in profitability, with a 0.37% increase in profit. The company's net worth Soared by an impressive increase of 10.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Emmarlinkpharma had a promoter holding of 88.37% and a public holding of 11.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹180,199,000.00
₹172,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2024 | Axis Bank Limited | ₹0.90 M | Open |
| 10 Jan 2024 | Dhanlaxmi Bank Limited | ₹0.68 M | Open |
| 07 Mar 2022 | Axis Bank Limited | ₹17.86 Cr | Open |
| 12 May 2022 | Axis Bank Limited | ₹2.25 Cr | Satisfied |
| 18 Aug 2021 | Others | ₹8.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Emmarlinkpharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Emmarlinkpharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emmarlinkpharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 12 May 2022 via Charge ID 100587048 with Axis Bank Limited was fully satisfied on 18 Oct 2025. was documented.
Progress on Emmarlinkpharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 0.09 Cr with Charge ID 100925375 was registered on 10 May 2024. was completed.
The activity Emmarlinkpharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
The activity A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100858586 was registered on 10 Jan 2024. was completed.
Progress on A charge with Axis Bank Limited of Rs. 17.86 Cr registered on 07 Mar 2022 with Charge ID 100574462 was modified on 05 Jul 2023. was documented.
The CIN of Emmarlinkpharma Private Limited is U74999KL2019PTC057236.
Emmarlinkpharma Private Limited is headquartered at Building No. 52/5287 Haji Building, Fort Road, Kannur, Kerala, 670001.
Emmarlinkpharma Private Limited was incorporated on 19 March 2019.
The current directors of Emmarlinkpharma Private Limited are
The primary industry of Emmarlinkpharma Private Limited is Trade.
Emmarlinkpharma Private Limited is unlisted.
The authorized capital of Emmarlinkpharma Private Limited is ₹7.30 Cr, and the paid-up capital is ₹6.41 Cr.
The compliance status of Emmarlinkpharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX